The future of anticancer agents looks promising with advances in various areas:
Precision Medicine: Tailoring treatments based on genetic and molecular profiling of each patient's cancer. Combination Therapies: Using multiple agents to target different pathways and reduce resistance. Nanotechnology: Developing nanoparticles for targeted drug delivery to minimize side effects. Artificial Intelligence: Utilizing AI to predict treatment responses and optimize drug development.
